Researcher
Debby Thomas
- Disciplines:Laboratory medicine, Regenerative medicine, Other basic sciences, Other health sciences, Other medical and health sciences, Medical biotechnology, Drug discovery and development, Pharmaceutics
Affiliations
- Therapeutic and Diagnostic Antibodies (Division)
Member
From1 Jun 2017 → 30 Sep 2022 - Gynaecological Oncology (Division)
Member
From1 Mar 2014 → 31 May 2017 - Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE) (Division)
Member
From1 Mar 2010 → 28 Feb 2014
Projects
1 - 2 of 2
- Symmetric antibodies for symmetric epitopes: development and validation of the Symbody platform.From1 Oct 2021 → TodayFunding: IOF - technology validation in lab
- Deciphering Tau structure and oligomerization propensities: Towards innovative therapeutics, prognostics and diagnosticsFrom1 Jan 2021 → 31 Dec 2023Funding: IOF - technology validation in lab
Publications
11 - 20 of 49
- Real-world Endoscopic and Histological Outcomes Are Correlated with Ustekinumab Exposure in Patients with Ulcerative Colitis(2022)
Authors: Dahham Alsoud, Gert De Hertogh, João Guedelha Sabino, Marc Ferrante, Debby Thomas, Séverine Vermeire, Bram Verstockt
Pages: 1562 - 1570 - Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model(2022)
Authors: Debby Thomas, Maarten Dewilde, Nick Geukens, Paul Declerck
- Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases(2022)
Authors: Wannee Kantasiripitak, Alex Kensert, Zhigang Wang, João Guedelha Sabino, Séverine Vermeire, Debby Thomas, Marc Ferrante, Erwin Dreesen
Pages: 1045 - 1059 - Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis(2022)
Authors: Rani Soenen, Zhigang Wang, Erwin Dreesen, Paul Declerck, Debby Thomas
Pages: 1324 - 1336 - Point-of-care therapeutic drug monitoring of adalimumab by integrating a FO-SPR biosensor in a self-powered microfluidic cartridge(2022)
Authors: Henry Ordutowski, Charlotte Van Tricht, Mattijs Bulcaen, Marta Ciwinska, Caro Gutierrez Cisneros, Xander Janssens, Nick Geukens, Debby Thomas, Francesco Dal Dosso, Dragana Spasic, et al.
- Development and validation of a microfluidic multiplex immunoassay for the determination of levels and avidity of serum antibodies to tetanus, diphtheria and pertussis antigens(2022)
Authors: Debby Thomas, Maaike Cockx, Louanne Ampofo, Nick Geukens, Xavier Bossuyt
- Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases(2022)
Authors: Debby Thomas, Séverine Vermeire, Peter Bossuyt
Pages: 208 - 217 - The value of therapeutic drug monitoring to guide treatment optimisation of biologicals in patients with chronic inflammatory diseases: focus on vedolizumab and ustekinumab(2021)
Authors: Nathalie Van den Berghe, Séverine Vermeire, Debby Thomas
- Precise sample metering method by coordinated burst action of hydrophobic burst valves applied to dried blood spot collection(2021)
Authors: Dries Vloemans, Lorenz Van Hileghem, Wannes Verbist, Debby Thomas, Francesco Dal Dosso, Jeroen Lammertyn
Pages: 1 - 10 - The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases(2021)
Authors: Wannee Kantasiripitak, Bram Verstockt, Dahham Alsoud, Debby Thomas, Séverine Vermeire, Marc Ferrante, Erwin Dreesen
Pages: 3776 - 3789